Clinical trials
Observational Leiomyoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
111 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 12 |
| 2024 | 9 |
| 2025 | 13 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Unknown status | 24 |
| Recruiting | 14 |
| Terminated | 9 |
| Not yet recruiting | 8 |
| Withdrawn | 6 |
| Active, not recruiting | 6 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Environmental Health Sciences (NIEHS) | 4 |
| Allergan | 3 |
| Gynesonics | 3 |
| Igenomix | 3 |
| Tongji Hospital | 3 |
| Wenwen Wang | 3 |
| AbbVie | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Ain Shams University | 2 |
| Assiut University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leiomyoma | 111 |
| Myofibroma | 15 |
| Endometriosis | 10 |
| Adenomyosis | 9 |
| Infertility | 6 |
| Menorrhagia | 6 |
| Infertility, Female | 5 |
| Uterine Neoplasms | 5 |
| Leiomyosarcoma | 4 |
| Myoma | 4 |
Trials
Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.
11 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.